
|Articles|November 15, 2003
NEI to test intraocular implant to thwart RP
Paris-Neurotech SA is initiating a phase I clinical trial of NT-501, its lead Encapsulated Cell Technology (ECT) product for the treatment of retinitis pigmentosa (RP).
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Regeneron's EYLEA HD injection 8 mg approved by FDA for the treatment of macular edema following RVO
2
Corza Medical announces launch of the SensorTek ROP Kit
3
Defining Retinal Vascular Diseases AMD, DME, RVO
4
EyePoint receives second consecutive positive recommendation from DSMC
5


















































.png)


